John Johnson, CEO, Director at Melinta Therapeutics, holds 37.40K shares in Melinta Therapeutics (Ticker: MLNTQ), holds ― shares in AVEO Pharma (Ticker: AVEO), holds 522.15K shares in Strongbridge Biopharma (Ticker: SBBP). Most recently, John Johnson Sold ― shares of Melinta Therapeutics on Jul 02, 2019 for an estimated value of 72.41K.
What is the percentage of profitable transactions made by John Johnson?
The percentage of profitable transactions made by John Johnson is 67%.
What is the average return per transaction made by John Johnson?
The average return per transaction made by John Johnson is 118.80%.
What stocks does John Johnson hold?
John Johnson holds: MLNTQ, AVEO, SBBP, VSTM, SCMP, PTLA, OCGN, DNDNQ, LLY, SVNTQ, OCRX stocks.
What was John Johnson’s latest transaction?
John Johnson latest transaction was an Informative Sell of $72.41K.
What was John Johnson's most profitable transaction?
John Johnson’s most profitable transaction was an Informative Buy of MLNTQ stock on May 28, 2014. The return on the trade was 297.50%.
What is John Johnson's role in Melinta Therapeutics?
John Johnson's role in Melinta Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.